# High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment

> **NCT03405584** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 160 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Amoxicillin
- **DRUG:** Bismuth Potassium Citrate

## Key facts

- **NCT ID:** NCT03405584
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-03
- **Primary completion:** 2018-11-02
- **Final completion:** 2018-11-02
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405584, "High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03405584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*